BINDING OF METALLOBLEOMYCIN TO SYNTHETIC DNA
金属博莱霉素与合成 DNA 的结合
基本信息
- 批准号:6279869
- 负责人:
- 金额:$ 0.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 1999-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Among the agents used to treat human cancer, at least three
require metals for their activity, i.e., cis-diamminedichloro Pt(II),
bleomycin (Blm), and adriamycin. Of the three, Blm has the most
elaborate structure and most complicated chemistry. Blm causes
double-strand scission in cells and, because double-strand scission is
correlated with inhibition of cell proliferation and is poorly
repaired, this type of DNA damage is likely to be responsible for
anticancer properties of this compound. In 1997, a new project with
graduate student C. Xia was initiated. ESR spectra over time for O2
Co(II) Blm bound to 10-mers with a specific GC binding site or a
nonspecific AT binding site were obtained to determine the viability
of the O2 Co(II) Blm-DNA adduct for NMR studies. It was found that
the half-like for the conversion of O2 Co(II) Blm to H O2 Co(III) Blm
is days under our conditions. This reaction corresponded with a
change from fast-exchanage data to slow-exchange data from the NMR
studies. A second EPR study with graduate student Chunwu Xia was
completed to follow the time course of the cyanide adduct of Fe(III)
Blm, NC-Fe(III) Blm, upon addition of 10-mers with specific and
nonspecific binding sites for FeBlm. Cyanide was slowly released upon
binding drug to the 10-mer with the specific, GC, binding site as
determined by formation of the low-spin ESR signal for Fe(III) Blm
bound toDNA. The low-spin signal did not form over time upon addition
of the nonspecific, AT, 10-mer to NC-Fe(III) Blm. Since Fe(III) Blm
bound to DNA can bind nitric oxide, carbon monoxide, and hydrogen
peroxide, it is not clear why cyanide is released upon binding of the
specific, GC, 10-mer.
在用于治疗人类癌症的药物中,至少有三种
它们的活性需要金属,即顺式二氨基二氯铂(II),
博莱霉素(BLM)和阿霉素。在这三家公司中,BLM拥有最多
精细的结构和最复杂的化学。博莱姆引起的
细胞中的双链断裂,因为双链断裂是
与细胞增殖抑制相关,且表现不佳
修复后,这种类型的DNA损伤很可能是
该化合物的抗癌性能。1997年,一个新的项目,
研究生夏志强是启蒙的。O2随时间变化的ESR谱
与10-MERS结合的具有特定GC结合位点或
获得非特异的AT结合位点以确定其活性
O2Co(II)BLm-DNA加合物用于核磁共振研究。结果发现,
O2-Co(II)BLm转化为H-O2-Co(III)BLm的半相似反应
在我们的条件下是几天。这种反应相当于一种
从快速交换数据到核磁共振慢交换数据的转变
学习。对研究生夏春武的第二次EPR研究是
完成跟踪Fe(III)的氰化物加合物的时间过程
BLm,NC-Fe(III)BLm,在添加具有特定和
FeBlm的非特异性结合位点。氰化物被缓慢释放到
将药物结合到具有特定GC结合部位的10-聚体
由Fe(III)BLM的低自旋ESR信号的形成所确定
与DNA结合。低自旋信号不是在相加时随时间而形成的
非特异性的AT,10-聚体对NC-Fe(III)BLm。由于Fe(III)BLm
与DNA结合可以结合一氧化氮、一氧化碳和氢气
过氧化氢,尚不清楚为什么氰化物在结合时被释放
特异性,GC,10-聚体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H PETERING其他文献
DAVID H PETERING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H PETERING', 18)}}的其他基金
METALLOBLEOMYCIN DNA INTERACTIONS AT SPECIFIC BINDING SITES
金属博莱霉素 DNA 在特定结合位点的相互作用
- 批准号:
6118849 - 财政年份:1999
- 资助金额:
$ 0.54万 - 项目类别:
METAL THIOLATE CLUSTERS IN CO(II) METALLOTHIONEIN
CO(II) 金属硫蛋白中的金属硫醇盐簇
- 批准号:
6279868 - 财政年份:1998
- 资助金额:
$ 0.54万 - 项目类别:
CADMIUM, ZINC, METALLOTHIONEIN AND KIDNEY CYTOTOXICITY
镉、锌、金属硫蛋白和肾细胞毒性
- 批准号:
3895900 - 财政年份:
- 资助金额:
$ 0.54万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 0.54万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 0.54万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 0.54万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 0.54万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 0.54万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 0.54万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 0.54万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 0.54万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 0.54万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 0.54万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




